Mochi Health Semaglutide Cost: Per-Dose Pricing & Membership Fees

Last reviewed: September 14, 2026 Last updated: September 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mochi Health charges $60/month for starting-dose compounded semaglutide injection (medication only) plus a membership fee—$39 for the first month (introductory rate), with the ongoing membership rate requiring confirmation at signup. That puts the documented first-month all-in cost at $99. The platform uses a per-dose pricing model, meaning cost increases as your dose escalates, though the specific tier pricing is not publicly listed. PlexusDx charges a flat $189/month for compounded semaglutide injection at any dose with no membership fee. Over 12 months at starting dose—if Mochi's membership remained at the introductory $39/month rate—Mochi would total $1,188 versus PlexusDx's $2,268, a difference of $1,080 (our calculation). The trade-off: Mochi's lower entry price rises with dose; PlexusDx holds the same rate whether you're on 0.25 mg or 2.4 mg.

At-a-glance comparison

Sources: joinmochi.com, plexusdx.com, Trustpilot. Mochi ongoing membership rate and dose-escalation pricing require confirmation at checkout.

Mochi Health semaglutide pricing breakdown

Mochi Health moved to a per-dose pricing model in 2024, separating medication cost from membership. For compounded semaglutide injection, the starting dose costs $60/month for the medication itself (joinmochi.com/medications/compounded-tirzepatide, captured 2026-09-04). A membership fee applies: the introductory first-month rate is $39, with the standard ongoing monthly membership rate not specified in public documentation (joinmochi.com/blog/per-dose-pricing-mochi-health, captured 2026-09-04). Confirm the standard membership rate at signup.

The documented first-month all-in cost is therefore $60 (medication) + $39 (first-month introductory membership) = $99. If the membership remained at the introductory $39/month rate in subsequent months, the monthly cost would stay $99 until your clinician escalates your dose. Mochi's per-dose model means your medication cost rises as your dose increases, though the platform does not publish the specific pricing tiers for higher doses (joinmochi.com/blog/per-dose-pricing-mochi-health, captured 2026-09-04). You will see the updated cost when your provider adjusts your prescription.

What's included

Mochi's membership fee is billed separately from medication. The evidence does not detail which services the membership covers; typical telehealth memberships bundle provider consultations, prescription management, and care coordination, but confirm the scope at enrollment.

PlexusDx semaglutide pricing (flat rate, no membership)

PlexusDx charges $189/month for compounded semaglutide injection on a month-to-month basis, with no membership fee (plexusdx.com/products/semaglutide-injection, verified 2026-07-17 to 2026-07-23). The rate holds at every dose—whether you are prescribed 0.25 mg, 1 mg, or 2.4 mg, the monthly cost remains $189. Three-month and six-month prepaid plans reduce the effective monthly rate to $169 and $149 respectively (our calculation of prepaid per-month equivalents; billed as $507 every three months or $894 every six months).

The all-in price includes your online provider visit, prescription, compounded medication, and shipping. There are no setup fees, membership charges, or per-visit fees.

12-month cost comparison (starting dose, month-to-month)

We normalize the 12-month cost at starting dose using documented figures and transparent assumptions. For Mochi, we calculate two scenarios: one assuming the introductory first-month $39 membership fee continues at that rate (unconfirmed), and one showing medication cost only.

Mochi Health semaglutide (starting dose, monthly billing)

Scenario A (assuming introductory $39/month membership ongoing):

• Month 1: $60 medication + $39 membership = $99
• Months 2–12: $60 + $39 = $99 × 11 = $1,089
• 12-month total: $1,188 (our calculation)
• Average monthly: $99

Scenario B (medication only, membership unknown after month 1):

• Medication: $60 × 12 = $720
• Membership after month 1: not publicly documented

Limitation: Mochi does not publish the standard ongoing membership rate or dose-escalation pricing. Scenario A is illustrative; confirm both at signup. Dose increases will raise the medication component.

PlexusDx semaglutide (month-to-month, any dose)

• $189 × 12 = $2,268
• Average monthly: $189

Difference (Scenario A): Mochi $1,188 vs PlexusDx $2,268 = PlexusDx costs $1,080 more over 12 months at starting dose (our calculation, assuming Mochi membership remains at the introductory $39/month rate).

Per-dose versus flat-rate: decision factors

Mochi's per-dose model advantage

If you remain on a low starting dose—either because you respond well at that level or you are using semaglutide for maintenance—Mochi's $60/month medication charge plus membership delivers a materially lower monthly cost than PlexusDx's $189 flat rate (assuming the membership fee remains modest). Patients who do not require dose escalation, or who escalate slowly, may see sustained savings.

Mochi's per-dose model limitation

Cost predictability erodes as dose rises. The platform does not publish its tiered medication pricing, so you will not know your all-in monthly cost at 1 mg or 2.4 mg until your provider adjusts your prescription. For patients who escalate to therapeutic doses quickly, the gap between Mochi and a flat-rate plan narrows or reverses. The ongoing membership rate—beyond the documented introductory $39 first month—also requires confirmation, which affects long-term budget planning.

PlexusDx flat-rate advantage

Cost certainty from day one. Whether your provider prescribes 0.25 mg or 2.4 mg, your monthly charge remains $189 (month-to-month) or $149 (six-month plan). Patients who know they will titrate to higher doses, or who prioritize fixed budgeting, benefit from rate stability. No membership fee simplifies the invoice.

Review and service-quality context

Mochi Health holds a 4.5-star rating on Trustpilot with approximately 18,000 reviews (Trustpilot.com, captured 2026-09-04), indicating broad user engagement and predominantly positive feedback. One individual Trustpilot report captured alleged a provider appearing late and not engaging during the consultation (captured 2026-09-04); this is an anecdotal allegation, not a verified systemic issue, but prospective patients may wish to confirm consultation protocols during enrollment.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (Trustpilot.com/review/plexusdx.com, captured 2026-09-09). Both platforms operate in the same compounded-telehealth category; review volume favors Mochi, while star averages are comparable.

Tirzepatide pricing (brief comparison)

Mochi charges $90/month for starting-dose compounded tirzepatide injection, plus the same membership structure (introductory first-month rate of $39, ongoing rate unconfirmed). First-month all-in: $129. PlexusDx charges $289/month month-to-month for compounded tirzepatide at any dose, or $249/month on a six-month plan (our calculation of the prepaid per-month equivalent). Over 12 months at starting dose, assuming Mochi's membership remains at the introductory $39/month rate: Mochi $1,548 versus PlexusDx $3,468, a difference of $1,920 (our calculation). The same dose-escalation and membership-rate caveats apply.

Choose Mochi Health if…

• You expect to remain on a low starting dose for an extended period, or you are using semaglutide for weight maintenance rather than active loss.
• You value the flexibility of monthly billing and are comfortable confirming dose-tier pricing and ongoing membership rates at signup.
• The lower documented entry price ($99 first month for semaglutide) fits your immediate budget, and you plan to reassess as your dose changes.
• You prefer a platform with high review volume and are reassured by Mochi's 4.5-star Trustpilot rating.

Choose PlexusDx if…

• You want full cost certainty from enrollment through maintenance—one rate at every dose, no membership fee, no surprise increases when your provider escalates your prescription.
• You anticipate titrating to therapeutic doses (1 mg or higher for semaglutide, 10 mg or higher for tirzepatide) and want to lock in a flat rate before escalation.
• You prefer prepaid multi-month plans that lower the effective monthly cost ($149/month for semaglutide, $249/month for tirzepatide on six-month terms).
• You value transparent, published pricing with no confirmation required at checkout.

Methodology and freshness

We captured Mochi Health pricing and product details from joinmochi.com/blog/per-dose-pricing-mochi-health and joinmochi.com/medications/compounded-tirzepatide on 2026-09-04. Trustpilot ratings for Mochi were captured the same day; PlexusDx Trustpilot data verified 2026-09-09. PlexusDx commercial terms verified 2026-07-17 through 2026-07-23. The 12-month cost calculations, prepaid per-month equivalents, and cost differences are our calculations, derived from the captured figures using transparent arithmetic. We label all promotional or introductory rates (Mochi's introductory $39 first-month membership) and note when ongoing rates require confirmation. Mochi's dose-escalation pricing is not publicly listed; we state that limitation plainly. No price figure appears without its source and capture date.

Frequently Asked Questions

Does Mochi Health's semaglutide price stay at $60/month?

The $60/month rate applies to the starting dose only. Mochi uses a per-dose pricing model, so your medication cost increases when your provider escalates your dose. The platform does not publish the specific pricing tiers for higher doses; you will see the updated cost when your prescription changes.

What is Mochi's ongoing membership fee after the first month?

Mochi charges an introductory $39 for the first month of membership (captured 2026-09-04). The evidence does not confirm the standard membership rate for subsequent months. Check the ongoing membership cost during signup or contact Mochi directly before enrolling.

How does PlexusDx's flat-rate pricing work at higher doses?

PlexusDx charges the same monthly rate regardless of dose. Whether you are prescribed 0.25 mg or 2.4 mg of semaglutide, the cost remains $189/month (month-to-month) or $149/month (six-month plan). There is no dose-escalation surcharge and no membership fee.

Which provider is cheaper over 12 months?

At starting dose with assumed introductory $39/month membership, Mochi totals $1,188 for semaglutide versus PlexusDx's $2,268 (month-to-month), a difference of $1,080 (our calculation). If you escalate dose, Mochi's cost rises while PlexusDx holds flat. The crossover depends on your dose trajectory and Mochi's undisclosed tier pricing.

Are compounded semaglutide medications FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both Mochi and PlexusDx offer compounded semaglutide prepared by licensed compounding pharmacies.

Sources

• Mochi Health per-dose pricing announcement: joinmochi.com/blog/per-dose-pricing-mochi-health (accessed 2026-09-04)
• Mochi Health compounded tirzepatide product page: joinmochi.com/medications/compounded-tirzepatide (accessed 2026-09-04)
• Mochi Health Trustpilot profile (accessed 2026-09-04)
• PlexusDx semaglutide injection product page: plexusdx.com/products/semaglutide-injection (verified 2026-07-17 to 2026-07-23)
• PlexusDx Trustpilot profile: trustpilot.com/review/plexusdx.com (verified 2026-09-09)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.